Diamond Biofund Inc.

Equities

6901

TW0006901002

Investment Management & Fund Operators

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 30/06/2024 BST			5-day change	1st Jan Change
45.2 ^TWD	+1.12%		+6.48%	-7.38%

05-21	Diamond Biofund Inc. Announces Changes to Its Board	CI
05-21	Diamond Biofund Inc. Approves Election of Directors of Board	CI

Diamond Biofund Inc. Approves Election of Directors of Board

May 21, 2024 at 09:00 am

Diamond Biofund Inc. at its shareholders meeting held on May 21, 2024, approved the amendments to the Company's Articles of Incorporation. institutional director: Oneness Biotech Co. Ltd.; Representative:Pan-Chih Yang; institutional director: Oneness Biotech Co.

Ltd.; Representative: Tsu-Der Lee; natural-person director:Che-An Chou; independent director: Te-Tsai Li; independent director:Fei-Peng Li; independent director:Shu-Hui Chang; independent director:Li-Ching Chen; independent director:Chi-Yu Hsiang; independent director:Shih-Tsung Chang.

Latest news about Diamond Biofund Inc.

Diamond Biofund Inc. Announces Changes to Its Board	05-21	CI
Diamond Biofund Inc. Approves Election of Directors of Board	05-21	CI
Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
Diamond Biofund Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Diamond Biofund Inc. Announces Chief Financial Officer Changes	12-22	CI
Diamond Biofund Inc.(TWSE:6901) added to Taiwan TAIEX Index	12-15	CI
Diamond Biofund Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Diamond Biofund Inc. has completed an IPO in the amount of TWD 4 billion.	15/09/23	CI
Diamond Biofund Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23	CI
Diamond Biofund Inc. Appoints Patricia Chou as CFO	20/07/23	CI
Diamond Biofund Inc. Announces a Cash Dividend, Payable on September 8, 2023	20/07/23	CI
Diamond Biofund Inc. has filed an IPO in the amount of TWD 4 billion.	20/07/23	CI
Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Diamond Biofund Inc.(TPEX:6901) added to S&P Global BMI Index	19/12/22	CI
Ativa Medical Corporation announced that it has received $15 million in funding from Ping An Ventures, Zhejiang Dian Diagnostics Co., Investment Arm, Diamond Biofund Inc., Hermed Capital co.,Ltd, Laboratory Corp. of America Holdings, GIMDx, and other investors.	27/08/15	CI
Ativa Medical Corporation announced that it expects to receive $15 million in funding.	13/08/15	CI

Chart Diamond Biofund Inc.

Duration

Period

More charts

Company Profile

Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.

Sector

Investment Management & Fund Operators

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
DIAMOND BIOFUND INC.	-7.38%	1.17B
BLACKROCK, INC.	-3.64%	117B
UBS GROUP AG	+3.37%	94.38B
APOLLO GLOBAL MANAGEMENT, INC.	+26.70%	67.18B
BROOKFIELD CORPORATION	+7.06%	64.45B
BANK OF NEW YORK MELLON CORPORATION (THE)	+15.49%	44.79B
AMERIPRISE FINANCIAL, INC.	+12.18%	42.43B
3I GROUP PLC	+23.34%	37.37B
T. ROWE PRICE GROUP INC.	+5.72%	25.75B
STATE STREET CORPORATION	-5.03%	22.29B

Other Investment Management & Fund Operators